These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24279471)

  • 1. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
    Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
    CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
    Wang H; Zhao Y; Zhang C; Li M; Jiang C; Li Y
    PLoS One; 2014; 9(2):e89782. PubMed ID: 24587032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
    Bao Z; Zhang C; Yan W; Liu Y; Li M; Zhang W; Jiang T
    J Transl Med; 2013 Apr; 11():100. PubMed ID: 23590708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.
    Zhang CB; Zhu P; Yang P; Cai JQ; Wang ZL; Li QB; Bao ZS; Zhang W; Jiang T
    Oncotarget; 2015 Nov; 6(34):36643-51. PubMed ID: 26436699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
    J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
    Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
    Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
    J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
    Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ
    J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
    Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
    Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immune-related lncRNA signature for patients with anaplastic gliomas.
    Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
    J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas.
    Yang Y; Chen X; Sun J; Chen S; Yang C; Ma Q; Yang J
    Sci Rep; 2021 Sep; 11(1):19493. PubMed ID: 34593910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classifying lower grade glioma cases according to whole genome gene expression.
    Chen B; Liang T; Yang P; Wang H; Liu Y; Yang F; You G
    Oncotarget; 2016 Nov; 7(45):74031-74042. PubMed ID: 27677590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
    Zeng F; Wang K; Liu X; Zhao Z
    Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.